ONTOLOGY REPORT - ANNOTATIONS
| Term: | 5-aza-2'-deoxycytidine |
|
| Accession: | CHEBI:50131
|
browse the term
|
| Definition: | A 2'-deoxyribonucleoside that has formula C8H12N4O4. |
| Synonyms: | exact_synonym: | 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one |
| | related_synonym: | 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one; 5-azadeoxycytidine; C8H12N4O4; InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1; InChIKey=XAUDJQYHKZQPEU-KVQBGUIXSA-N; Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1; decitabine |
| | xref_casrn: | 2353-33-5 |
| | xref: | Beilstein:617982 "Beilstein Registry Number"; ChEMBL:775080 "ChEMBL COMPOUND"; ChemIDplus:2353-33-5 "CAS Registry Number"; DrugBank:DB01262 "DrugBank" |
| | xref_mesh: | MESH:C014347 |
| | xref: | Wikipedia:Decitabine "Wikipedia" |
|
|
5-aza-2'-deoxycytidine
|
| G |
1700102P08Rik |
RIKEN cDNA 1700102P08 gene |
|
decreases expression |
ISO |
9 |
108,295,165 |
108,300,101 |
RGD:6480464 |
CTD |
| G |
1700102P08Rik |
RIKEN cDNA 1700102P08 gene |
|
multiple interactions |
ISO |
9 |
108,295,165 |
108,300,101 |
RGD:6480464 |
CTD |
| G |
3110057O12Rik |
RIKEN cDNA 3110057O12 gene |
|
decreases expression |
ISO |
3 |
40,698,199 |
40,740,229 |
RGD:6480464 |
CTD |
| G |
3110057O12Rik |
RIKEN cDNA 3110057O12 gene |
|
multiple interactions |
ISO |
3 |
40,698,199 |
40,740,229 |
RGD:6480464 |
CTD |
| G |
5730559C18Rik |
RIKEN cDNA 5730559C18 gene |
|
increases expression |
ISO |
1 |
138,110,108 |
138,130,841 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
increases expression |
ISO |
16 |
20,331,376 |
20,426,467 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
affects expression |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
multiple interactions |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abt1 |
activator of basal transcription 1 |
|
decreases methylation |
EXP |
13 |
23,510,230 |
23,515,735 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-Coenzyme A dehydrogenase, very long chain |
|
increases expression |
ISO |
11 |
69,823,694 |
69,828,909 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
affects expression |
ISO |
9 |
21,931,171 |
21,940,190 |
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
affects methylation |
ISO |
12 |
81,268,529 |
81,361,358 |
RGD:6480464 |
CTD |
| G |
Adamdec1 |
ADAM-like, decysin 1 |
|
increases expression |
ISO |
14 |
69,181,444 |
69,200,129 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
|
increases expression |
ISO |
16 |
85,794,072 |
85,803,360 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenergic receptor, alpha 1d |
|
affects methylation |
ISO |
2 |
131,371,093 |
131,388,021 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenergic receptor, alpha 1d |
|
multiple interactions |
ISO |
2 |
131,371,093 |
131,388,021 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenergic receptor, alpha 1d |
|
increases expression |
ISO |
2 |
131,371,093 |
131,388,021 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenergic receptor, alpha 2a |
|
affects expression |
ISO |
19 |
54,119,672 |
54,123,472 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenergic receptor, alpha 2a |
|
increases expression |
ISO |
19 |
54,119,672 |
54,123,472 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenergic receptor, beta 1 |
|
decreases methylation |
ISO |
19 |
56,796,862 |
56,799,352 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenergic receptor, beta 1 |
|
increases expression |
ISO |
19 |
56,796,862 |
56,799,352 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
affects expression |
ISO |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
affects expression |
ISO |
11 |
5,761,869 |
5,772,228 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
multiple interactions |
ISO |
11 |
5,761,869 |
5,772,228 |
RGD:6480464 |
CTD |
| G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) |
|
increases expression |
ISO |
2 |
26,449,107 |
26,459,730 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
multiple interactions |
ISO |
4 |
155,539,399 |
155,559,244 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
multiple interactions |
EXP |
4 |
101,091,894 |
101,140,376 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
decreases expression |
EXP |
4 |
101,091,894 |
101,140,376 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
|
affects methylation |
ISO |
10 |
5,987,070 |
6,080,212 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
|
multiple interactions |
ISO |
10 |
5,987,070 |
6,080,212 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
decreases activity |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase family 1, subfamily A3 |
|
affects expression |
ISO |
7 |
73,535,778 |
73,572,363 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase family 1, subfamily A3 |
|
increases expression |
ISO |
7 |
73,535,778 |
73,572,363 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
increases expression |
ISO |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase family 6, subfamily A1 |
|
decreases expression |
ISO |
12 |
85,771,667 |
85,791,900 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase family 6, subfamily A1 |
|
multiple interactions |
ISO |
12 |
85,771,667 |
85,791,900 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
increases expression |
ISO |
11 |
78,137,700 |
78,140,262 |
RGD:6480464 |
CTD |
| G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
multiple interactions |
EXP |
11 |
68,970,574 |
68,983,293 |
RGD:6480464 |
CTD |
| G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
decreases expression |
EXP |
11 |
68,970,574 |
68,983,293 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
decreases expression |
ISO |
10 |
80,267,993 |
80,270,393 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
multiple interactions |
ISO |
10 |
80,267,993 |
80,270,393 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
ISO |
8 |
18,691,337 |
18,741,551 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
multiple interactions |
ISO |
7 |
86,966,689 |
86,987,238 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases expression |
ISO |
7 |
86,966,689 |
86,987,238 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
multiple interactions |
ISO |
6 |
86,686,834 |
86,743,578 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
3 |
36,347,845 |
36,374,809 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
ISO |
3 |
36,347,845 |
36,374,809 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
multiple interactions |
ISO |
11 |
54,792,464 |
54,846,973 |
RGD:6480464 |
CTD |
| G |
Ap1s1 |
adaptor protein complex AP-1, sigma 1 |
|
increases expression |
ISO |
5 |
137,510,864 |
137,521,930 |
RGD:6480464 |
CTD |
| G |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
|
increases expression |
ISO |
X |
160,347,092 |
160,367,478 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
affects expression |
ISO |
10 |
90,452,056 |
90,545,488 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
10 |
90,452,056 |
90,545,488 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
10 |
90,452,056 |
90,545,488 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
10 |
90,452,056 |
90,545,488 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatosis polyposis coli |
|
affects methylation |
ISO |
18 |
34,380,638 |
34,481,844 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatosis polyposis coli |
|
decreases methylation |
ISO |
18 |
34,380,638 |
34,481,844 |
RGD:6480464 |
CTD |
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
affects methylation |
ISO |
9 |
30,957,142 |
31,019,400 |
RGD:6480464 |
CTD |
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
increases expression |
ISO |
9 |
30,957,142 |
31,019,400 |
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
multiple interactions |
ISO |
16 |
31,296,278 |
31,314,682 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases methylation |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Arhgap27 |
Rho GTPase activating protein 27 |
|
multiple interactions |
ISO |
11 |
103,192,814 |
103,206,016 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
affects methylation |
ISO |
3 |
121,656,244 |
121,719,072 |
RGD:6480464 |
CTD |
| G |
Arhgef10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
|
increases expression |
ISO |
8 |
14,911,717 |
15,001,085 |
RGD:6480464 |
CTD |
| G |
Arhgef16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
|
multiple interactions |
ISO |
4 |
153,652,579 |
153,674,004 |
RGD:6480464 |
CTD |
| G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
|
increases expression |
EXP |
X |
54,484,662 |
54,591,906 |
RGD:6480464 |
CTD |
| G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
|
multiple interactions |
EXP |
X |
54,484,662 |
54,591,906 |
RGD:6480464 |
CTD |
| G |
Arl4d |
ADP-ribosylation factor-like 4D |
|
increases expression |
ISO |
11 |
101,526,855 |
101,529,146 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
1 |
192,994,175 |
193,007,212 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated homolog (human) |
|
multiple interactions |
ISO |
9 |
53,245,227 |
53,344,776 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated homolog (human) |
|
affects localization |
ISO |
9 |
53,245,227 |
53,344,776 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated homolog (human) |
|
affects response to substance |
ISO |
9 |
53,245,227 |
53,344,776 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated homolog (human) |
|
affects methylation |
ISO |
9 |
53,245,227 |
53,344,776 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
ISO |
1 |
166,367,398 |
166,388,486 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
multiple interactions |
ISO |
11 |
69,413,252 |
69,419,462 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
multiple interactions |
EXP |
11 |
69,413,252 |
69,419,462 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
|
multiple interactions |
ISO |
10 |
127,520,363 |
127,527,444 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
9 |
95,758,016 |
95,852,063 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
affects localization |
ISO |
9 |
95,758,016 |
95,852,063 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
increases activity |
ISO |
9 |
95,758,016 |
95,852,063 |
RGD:6480464 |
CTD |
| G |
Axl |
AXL receptor tyrosine kinase |
|
multiple interactions |
ISO |
7 |
26,542,292 |
26,573,560 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc |
|
multiple interactions |
ISO |
5 |
138,422,749 |
138,431,461 |
RGD:6480464 |
CTD |
| G |
Azi2 |
5-azacytidine induced gene 2 |
|
multiple interactions |
ISO |
9 |
117,949,617 |
117,973,025 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
2 |
121,973,423 |
121,978,818 |
RGD:6480464 |
CTD |
| G |
B3galnt1 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 |
|
affects expression |
ISO |
3 |
69,378,108 |
69,402,783 |
RGD:6480464 |
CTD |
| G |
Bag2 |
BCL2-associated athanogene 2 |
|
decreases expression |
ISO |
1 |
33,802,329 |
33,814,595 |
RGD:6480464 |
CTD |
| G |
Bag2 |
BCL2-associated athanogene 2 |
|
multiple interactions |
ISO |
1 |
33,802,329 |
33,814,595 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
ISO |
17 |
27,156,757 |
27,165,571 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
BCL2 binding component 3 |
|
multiple interactions |
ISO |
7 |
16,894,932 |
16,903,683 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
BCL2 binding component 3 |
|
affects methylation |
ISO |
7 |
16,894,932 |
16,903,683 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
decreases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
decreases methylation |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
11 |
101,149,581 |
101,163,581 |
RGD:6480464 |
CTD |
| G |
Bhmt2 |
betaine-homocysteine methyltransferase 2 |
|
multiple interactions |
EXP |
13 |
94,426,052 |
94,444,257 |
RGD:6480464 |
CTD |
| G |
Bhmt2 |
betaine-homocysteine methyltransferase 2 |
|
increases expression |
EXP |
13 |
94,426,052 |
94,444,257 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer |
|
multiple interactions |
ISO |
15 |
83,357,292 |
83,375,065 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer |
|
increases expression |
ISO |
15 |
83,357,292 |
83,375,065 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
affects expression |
ISO |
9 |
7,818,226 |
7,835,255 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
affects expression |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases methylation |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Bmf |
BCL2 modifying factor |
|
multiple interactions |
ISO |
2 |
118,354,493 |
118,375,414 |
RGD:6480464 |
CTD |
| G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
|
multiple interactions |
ISO |
2 |
18,598,645 |
18,608,256 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
2 |
133,378,935 |
133,388,621 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
multiple interactions |
ISO |
13 |
38,437,585 |
38,591,597 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
decreases methylation |
ISO |
2 |
172,695,187 |
172,765,794 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
ISO |
2 |
172,695,187 |
172,765,794 |
RGD:6480464 |
CTD |
| G |
Bnc1 |
basonuclin 1 |
|
affects expression |
ISO |
7 |
89,111,548 |
89,137,185 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
EXP |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
increases expression |
ISO |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases methylation |
ISO |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
EXP |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1 |
|
affects localization |
ISO |
11 |
101,350,078 |
101,413,269 |
RGD:6480464 |
CTD |
| G |
Brf2 |
BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like |
|
increases expression |
ISO |
8 |
28,234,304 |
28,239,104 |
RGD:6480464 |
CTD |
| G |
Bsn |
bassoon |
|
decreases expression |
ISO |
9 |
107,998,353 |
108,092,714 |
RGD:6480464 |
CTD |
| G |
Bsn |
bassoon |
|
multiple interactions |
ISO |
9 |
107,998,353 |
108,092,714 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
affects expression |
ISO |
8 |
74,058,158 |
74,061,336 |
RGD:6480464 |
CTD |
| G |
Btg3 |
B cell translocation gene 3 |
|
decreases methylation |
ISO |
16 |
78,360,105 |
78,377,030 |
RGD:6480464 |
CTD |
| G |
Btg3 |
B cell translocation gene 3 |
|
increases expression |
ISO |
16 |
78,360,105 |
78,377,030 |
RGD:6480464 |
CTD |
| G |
Bub1b |
budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
118,423,947 |
118,467,328 |
RGD:6480464 |
CTD |
| G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
|
multiple interactions |
ISO |
15 |
78,354,516 |
78,360,047 |
RGD:6480464 |
CTD |
| G |
C1rl |
complement component 1, r subcomponent-like |
|
increases expression |
ISO |
6 |
124,443,131 |
124,460,661 |
RGD:6480464 |
CTD |
| G |
C78339 |
expressed sequence C78339 |
|
increases expression |
ISO |
13 |
46,764,891 |
46,771,142 |
RGD:6480464 |
CTD |
| G |
Cables1 |
CDK5 and Abl enzyme substrate 1 |
|
affects methylation |
ISO |
18 |
11,997,783 |
12,104,136 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
affects expression |
ISO |
9 |
47,338,435 |
47,661,468 |
RGD:6480464 |
CTD |
| G |
Cage1 |
cancer antigen 1 |
|
multiple interactions |
ISO |
13 |
38,097,921 |
38,128,806 |
RGD:6480464 |
CTD |
| G |
Camta2 |
calmodulin binding transcription activator 2 |
|
increases expression |
ISO |
11 |
70,482,968 |
70,501,436 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2 |
|
multiple interactions |
ISO |
1 |
184,397,390 |
184,447,614 |
RGD:6480464 |
CTD |
| G |
Capn3 |
calpain 3 |
|
decreases expression |
ISO |
2 |
120,289,329 |
120,330,655 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
decreases expression |
ISO |
7 |
105,270,075 |
105,326,703 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
multiple interactions |
ISO |
7 |
105,270,075 |
105,326,703 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
increases expression |
ISO |
9 |
66,561,493 |
66,614,652 |
RGD:6480464 |
CTD |
| G |
Carhsp1 |
calcium regulated heat stable protein 1 |
|
increases expression |
ISO |
16 |
8,658,680 |
8,672,246 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases expression |
ISO |
3 |
129,604,343 |
129,617,020 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases cleavage |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases methylation |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases cleavage |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casz1 |
castor zinc finger 1 |
|
increases expression |
ISO |
4 |
148,178,501 |
148,329,001 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Ccdc18 |
coiled-coil domain containing 18 |
|
multiple interactions |
ISO |
5 |
108,561,933 |
108,661,970 |
RGD:6480464 |
CTD |
| G |
Ccdc18 |
coiled-coil domain containing 18 |
|
decreases expression |
ISO |
5 |
108,561,933 |
108,661,970 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
increases expression |
ISO |
9 |
121,398,942 |
121,404,807 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
1 |
83,113,341 |
83,115,742 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
affects methylation |
ISO |
3 |
54,849,391 |
54,858,977 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
affects expression |
ISO |
3 |
54,849,391 |
54,858,977 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects methylation |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
17 |
24,360,177 |
24,388,354 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
multiple interactions |
ISO |
17 |
24,360,177 |
24,388,354 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
9 |
124,016,922 |
124,023,879 |
RGD:6480464 |
CTD |
| G |
Ccr4 |
chemokine (C-C motif) receptor 4 |
|
affects expression |
ISO |
9 |
114,399,434 |
114,405,662 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 antigen |
|
multiple interactions |
ISO |
18 |
36,884,721 |
36,886,308 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 antigen |
|
multiple interactions |
ISO |
18 |
36,884,721 |
36,886,308 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 antigen |
|
increases expression |
ISO |
18 |
36,884,721 |
36,886,308 |
RGD:6480464 |
CTD |
| G |
Cd24a |
CD24a antigen |
|
increases expression |
ISO |
10 |
43,298,975 |
43,304,071 |
RGD:6480464 |
CTD |
| G |
Cd4 |
CD4 antigen |
|
increases expression |
ISO |
6 |
124,814,711 |
124,838,227 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 antigen |
|
increases expression |
ISO |
2 |
164,881,136 |
164,897,154 |
RGD:6480464 |
CTD |
| G |
Cd69 |
CD69 antigen |
|
affects expression |
ISO |
6 |
129,217,343 |
129,225,387 |
RGD:6480464 |
CTD |
| G |
Cd80 |
CD80 antigen |
|
increases expression |
ISO |
16 |
38,459,013 |
38,487,015 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
increases expression |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 antigen |
|
multiple interactions |
ISO |
6 |
125,410,284 |
125,444,773 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
increases degradation |
ISO |
4 |
137,894,443 |
137,923,870 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
34,892,651 |
34,911,187 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
multiple interactions |
ISO |
18 |
34,892,651 |
34,911,187 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects methylation |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases methylation |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases expression |
EXP |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
ISO |
8 |
105,156,895 |
105,309,011 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
ISO |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
ISO |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
decreases methylation |
ISO |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
increases expression |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
affects methylation |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
affects expression |
ISO |
8 |
101,552,669 |
101,940,357 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases phosphorylation |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
affects expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
decreases methylation |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects expression |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects methylation |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects methylation |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases methylation |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases methylation |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects expression |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects expression |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects methylation |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases methylation |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases methylation |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
4 |
88,952,198 |
88,956,941 |
RGD:6480464 |
CTD |
| G |
Cdkn2d |
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
|
increases expression |
ISO |
9 |
21,092,907 |
21,095,653 |
RGD:6480464 |
CTD |
| G |
Cdx1 |
caudal type homeobox 1 |
|
increases expression |
ISO |
18 |
61,178,516 |
61,195,853 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeobox 2 |
|
multiple interactions |
ISO |
5 |
148,112,476 |
148,118,825 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeobox 2 |
|
decreases methylation |
ISO |
5 |
148,112,476 |
148,118,825 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeobox 2 |
|
multiple interactions |
ISO |
5 |
148,112,476 |
148,118,825 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeobox 2 |
|
increases expression |
ISO |
5 |
148,112,476 |
148,118,825 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases methylation |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
affects methylation |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
affects methylation |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
ISO |
1 |
191,464,485 |
191,511,965 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
multiple interactions |
ISO |
1 |
191,464,485 |
191,511,965 |
RGD:6480464 |
CTD |
| G |
Cep110 |
centrosomal protein 110 |
|
decreases expression |
ISO |
2 |
34,965,012 |
35,034,342 |
RGD:6480464 |
CTD |
| G |
Cep110 |
centrosomal protein 110 |
|
multiple interactions |
ISO |
2 |
34,965,012 |
35,034,342 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
multiple interactions |
ISO |
9 |
13,612,232 |
13,631,537 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
decreases expression |
ISO |
9 |
13,612,232 |
13,631,537 |
RGD:6480464 |
CTD |
| G |
Ces1g |
carboxylesterase 1G |
|
increases abundance |
ISO |
8 |
95,826,268 |
95,861,108 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
affects expression |
ISO |
1 |
58,770,130 |
58,815,728 |
RGD:6480464 |
CTD |
| G |
Chd6 |
chromodomain helicase DNA binding protein 6 |
|
multiple interactions |
ISO |
2 |
160,772,714 |
160,934,792 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
affects localization |
ISO |
9 |
36,516,067 |
36,534,243 |
RGD:6480464 |
CTD |
| G |
Chfr |
checkpoint with forkhead and ring finger domains |
|
increases expression |
ISO |
5 |
110,564,859 |
110,600,991 |
RGD:6480464 |
CTD |
| G |
Chp1 |
calcineurin-like EF hand protein 1 |
|
affects methylation |
ISO |
2 |
119,373,443 |
119,412,760 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
|
multiple interactions |
ISO |
18 |
67,503,218 |
67,527,448 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
|
decreases methylation |
ISO |
18 |
67,503,218 |
67,527,448 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
|
increases expression |
ISO |
18 |
67,503,218 |
67,527,448 |
RGD:6480464 |
CTD |
| G |
Ciita |
class II transactivator |
|
multiple interactions |
ISO |
16 |
10,488,372 |
10,527,657 |
RGD:6480464 |
CTD |
| G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
increases expression |
ISO |
X |
99,442,775 |
99,447,108 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
|
multiple interactions |
EXP |
13 |
91,992,992 |
92,016,490 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
|
increases expression |
EXP |
13 |
91,992,992 |
92,016,490 |
RGD:6480464 |
CTD |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
increases expression |
ISO |
19 |
4,214,392 |
4,222,615 |
RGD:6480464 |
CTD |
| G |
Clcn2 |
chloride channel 2 |
|
increases expression |
EXP |
16 |
20,703,039 |
20,716,709 |
RGD:6480464 |
CTD |
| G |
Clcn2 |
chloride channel 2 |
|
multiple interactions |
EXP |
16 |
20,703,039 |
20,716,709 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
increases expression |
ISO |
X |
136,335,367 |
136,345,923 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
multiple interactions |
ISO |
5 |
135,462,084 |
135,463,342 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
increases expression |
ISO |
5 |
135,462,084 |
135,463,342 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
increases expression |
ISO |
5 |
135,462,084 |
135,463,342 |
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
decreases expression |
ISO |
17 |
35,187,188 |
35,195,664 |
RGD:6480464 |
CTD |
| G |
Cltc |
clathrin, heavy polypeptide (Hc) |
|
affects methylation |
ISO |
11 |
86,508,155 |
86,570,994 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
decreases methylation |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
multiple interactions |
EXP |
6 |
85,860,148 |
85,865,671 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
increases expression |
EXP |
6 |
85,860,148 |
85,865,671 |
RGD:6480464 |
CTD |
| G |
CN716893 |
expressed sequence CN716893 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cntn2 |
contactin 2 |
|
affects expression |
ISO |
1 |
134,406,002 |
134,439,517 |
RGD:6480464 |
CTD |
| G |
Cog8 |
component of oligomeric golgi complex 8 |
|
multiple interactions |
EXP |
8 |
109,572,609 |
109,580,637 |
RGD:6480464 |
CTD |
| G |
Col14a1 |
collagen, type XIV, alpha 1 |
|
increases expression |
ISO |
15 |
55,139,305 |
55,352,358 |
RGD:6480464 |
CTD |
| G |
Col17a1 |
collagen, type XVII, alpha 1 |
|
increases expression |
ISO |
19 |
47,720,831 |
47,766,532 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
decreases methylation |
ISO |
6 |
4,455,697 |
4,491,543 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
ISO |
6 |
4,455,697 |
4,491,543 |
RGD:6480464 |
CTD |
| G |
Col22a1 |
collagen, type XXII, alpha 1 |
|
multiple interactions |
ISO |
15 |
71,628,906 |
71,864,657 |
RGD:6480464 |
CTD |
| G |
Col8a2 |
collagen, type VIII, alpha 2 |
|
increases expression |
ISO |
4 |
125,964,038 |
125,991,574 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
increases expression |
ISO |
1 |
36,748,332 |
36,750,233 |
RGD:6480464 |
CTD |
| G |
Cpa3 |
carboxypeptidase A3, mast cell |
|
increases expression |
ISO |
3 |
20,115,515 |
20,142,080 |
RGD:6480464 |
CTD |
| G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
affects expression |
ISO |
7 |
88,492,329 |
88,599,562 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein I |
|
affects methylation |
ISO |
9 |
54,612,615 |
54,620,916 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein I |
|
multiple interactions |
ISO |
9 |
54,612,615 |
54,620,916 |
RGD:6480464 |
CTD |
| G |
Crisp2 |
cysteine-rich secretory protein 2 |
|
increases expression |
ISO |
17 |
40,901,686 |
40,931,039 |
RGD:6480464 |
CTD |
| G |
Crocc |
ciliary rootlet coiled-coil, rootletin |
|
increases expression |
ISO |
4 |
140,572,552 |
140,616,460 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases expression |
ISO |
2 |
152,052,576 |
152,107,588 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases activity |
ISO |
2 |
152,052,576 |
152,107,588 |
RGD:6480464 |
CTD |
| G |
Csnk2a2 |
casein kinase 2, alpha prime polypeptide |
|
increases expression |
ISO |
8 |
97,969,996 |
98,012,720 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
multiple interactions |
ISO |
2 |
148,697,468 |
148,701,204 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
affects expression |
ISO |
19 |
5,344,705 |
5,349,574 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
increases expression |
ISO |
19 |
5,344,705 |
5,349,574 |
RGD:6480464 |
CTD |
| G |
Cst7 |
cystatin F (leukocystatin) |
|
increases expression |
ISO |
2 |
150,396,151 |
150,404,680 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor |
|
multiple interactions |
ISO |
8 |
108,160,438 |
108,206,822 |
RGD:6480464 |
CTD |
| G |
Ctcfl |
CCCTC-binding factor (zinc finger protein)-like |
|
affects methylation |
ISO |
2 |
172,919,110 |
172,945,026 |
RGD:6480464 |
CTD |
| G |
Ctcfl |
CCCTC-binding factor (zinc finger protein)-like |
|
increases expression |
ISO |
2 |
172,919,110 |
172,945,026 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
increases expression |
EXP |
1 |
60,965,869 |
60,972,674 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases response to substance |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects localization |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
multiple interactions |
ISO |
9 |
89,949,105 |
89,970,933 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
9 |
89,949,105 |
89,970,933 |
RGD:6480464 |
CTD |
| G |
Ctsl |
cathepsin L |
|
increases expression |
ISO |
13 |
64,464,522 |
64,471,614 |
RGD:6480464 |
CTD |
| G |
Ctsz |
cathepsin Z |
|
affects expression |
ISO |
2 |
174,252,995 |
174,264,493 |
RGD:6480464 |
CTD |
| G |
Ctsz |
cathepsin Z |
|
multiple interactions |
ISO |
2 |
174,252,995 |
174,264,493 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
multiple interactions |
ISO |
16 |
78,301,936 |
78,360,030 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
affects methylation |
ISO |
5 |
92,775,667 |
92,777,880 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
6 |
117,118,553 |
117,131,386 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases methylation |
ISO |
6 |
117,118,553 |
117,131,386 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
decreases methylation |
ISO |
13 |
56,390,004 |
56,397,912 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
increases expression |
ISO |
13 |
56,390,004 |
56,397,912 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
decreases methylation |
ISO |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
affects methylation |
ISO |
5 |
92,750,357 |
92,757,105 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
affects expression |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cyld |
cylindromatosis (turban tumor syndrome) |
|
multiple interactions |
ISO |
8 |
91,220,927 |
91,275,844 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects methylation |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects methylation |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Dact1 |
dapper homolog 1, antagonist of beta-catenin (xenopus) |
|
multiple interactions |
ISO |
12 |
72,410,871 |
72,421,094 |
RGD:6480464 |
CTD |
| G |
Dact2 |
dapper homolog 2, antagonist of beta-catenin (xenopus) |
|
multiple interactions |
ISO |
17 |
14,332,237 |
14,340,838 |
RGD:6480464 |
CTD |
| G |
Dact3 |
dapper homolog 3, antagonist of beta-catenin (xenopus) |
|
affects expression |
ISO |
7 |
17,460,666 |
17,472,650 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
affects expression |
ISO |
13 |
60,703,308 |
60,864,547 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
multiple interactions |
ISO |
13 |
60,703,308 |
60,864,547 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
decreases methylation |
ISO |
13 |
60,703,308 |
60,864,547 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
increases expression |
ISO |
13 |
60,703,308 |
60,864,547 |
RGD:6480464 |
CTD |
| G |
Dapk2 |
death-associated protein kinase 2 |
|
increases expression |
ISO |
9 |
66,006,033 |
66,120,049 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
increases expression |
ISO |
10 |
80,645,752 |
80,655,942 |
RGD:6480464 |
CTD |
| G |
Dazl |
deleted in azoospermia-like |
|
increases expression |
ISO |
17 |
50,418,719 |
50,432,924 |
RGD:6480464 |
CTD |
| G |
Dbc1 |
deleted in bladder cancer 1 (human) |
|
multiple interactions |
ISO |
4 |
68,422,406 |
68,615,431 |
RGD:6480464 |
CTD |
| G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
|
multiple interactions |
ISO |
16 |
58,408,648 |
58,469,858 |
RGD:6480464 |
CTD |
| G |
Dcc |
deleted in colorectal carcinoma |
|
increases expression |
ISO |
18 |
71,413,286 |
72,510,723 |
RGD:6480464 |
CTD |
| G |
Dchs1 |
dachsous 1 (Drosophila) |
|
increases expression |
ISO |
7 |
112,901,503 |
112,936,064 |
RGD:6480464 |
CTD |
| G |
Dclk1 |
doublecortin-like kinase 1 |
|
affects expression |
ISO |
3 |
55,046,448 |
55,342,990 |
RGD:6480464 |
CTD |
| G |
Ddost |
dolichyl-di-phosphooligosaccharide-protein glycotransferase |
|
affects methylation |
ISO |
4 |
137,860,653 |
137,868,526 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, beta subunit |
|
affects methylation |
ISO |
4 |
153,338,558 |
153,349,190 |
RGD:6480464 |
CTD |
| G |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
|
increases expression |
ISO |
2 |
69,218,519 |
69,241,143 |
RGD:6480464 |
CTD |
| G |
Dip2c |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
|
increases expression |
ISO |
13 |
9,275,772 |
9,668,171 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf homolog 1 (Xenopus laevis) |
|
multiple interactions |
ISO |
19 |
30,620,366 |
30,623,986 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf homolog 1 (Xenopus laevis) |
|
decreases methylation |
ISO |
19 |
30,620,366 |
30,623,986 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf homolog 1 (Xenopus laevis) |
|
increases expression |
ISO |
19 |
30,620,366 |
30,623,986 |
RGD:6480464 |
CTD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
affects methylation |
ISO |
8 |
37,630,799 |
37,676,928 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
decreases methylation |
ISO |
12 |
110,691,033 |
110,701,546 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
ISO |
12 |
110,691,033 |
110,701,546 |
RGD:6480464 |
CTD |
| G |
Dlx2 |
distal-less homeobox 2 |
|
increases expression |
ISO |
2 |
71,381,465 |
71,384,811 |
RGD:6480464 |
CTD |
| G |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
|
increases expression |
ISO |
4 |
107,348,895 |
107,356,767 |
RGD:6480464 |
CTD |
| G |
Dnaja4 |
DnaJ (Hsp40) homolog, subfamily A, member 4 |
|
increases expression |
ISO |
9 |
54,547,366 |
54,564,119 |
RGD:6480464 |
CTD |
| G |
Dnajb3 |
DnaJ (Hsp40) homolog, subfamily B, member 3 |
|
increases expression |
ISO |
1 |
90,101,307 |
90,102,323 |
RGD:6480464 |
CTD |
| G |
Dnajc12 |
DnaJ (Hsp40) homolog, subfamily C, member 12 |
|
decreases expression |
ISO |
10 |
62,849,365 |
62,871,570 |
RGD:6480464 |
CTD |
| G |
Dnajc15 |
DnaJ (Hsp40) homolog, subfamily C, member 15 |
|
affects expression |
ISO |
14 |
78,226,024 |
78,274,724 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
multiple interactions |
EXP |
14 |
119,337,154 |
119,380,924 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
decreases expression |
EXP |
14 |
119,337,154 |
119,380,924 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
increases degradation |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
decreases expression |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
decreases expression |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
multiple interactions |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
increases expression |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
decreases expression |
EXP |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
affects response to substance |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
multiple interactions |
ISO |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA methyltransferase (cytosine-5) 1 |
|
affects response to substance |
EXP |
9 |
20,711,653 |
20,757,317 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA methyltransferase 3A |
|
multiple interactions |
ISO |
12 |
3,806,980 |
3,914,443 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA methyltransferase 3A |
|
decreases expression |
ISO |
12 |
3,806,980 |
3,914,443 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA methyltransferase 3A |
|
multiple interactions |
ISO |
12 |
3,806,980 |
3,914,443 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA methyltransferase 3A |
|
decreases expression |
ISO |
12 |
3,806,980 |
3,914,443 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
affects expression |
ISO |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
decreases expression |
ISO |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
multiple interactions |
ISO |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
decreases expression |
ISO |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
affects response to substance |
ISO |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
decreases expression |
EXP |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dok1 |
docking protein 1 |
|
increases expression |
ISO |
6 |
82,980,928 |
82,983,465 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
increases expression |
ISO |
8 |
97,387,728 |
97,400,212 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
affects expression |
ISO |
2 |
62,168,130 |
62,250,288 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
decreases methylation |
ISO |
3 |
118,265,096 |
119,135,836 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
increases expression |
ISO |
3 |
118,265,096 |
119,135,836 |
RGD:6480464 |
CTD |
| G |
Dsc3 |
desmocollin 3 |
|
affects expression |
ISO |
18 |
20,119,431 |
20,160,598 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
increases expression |
ISO |
5 |
104,599,731 |
104,609,146 |
RGD:6480464 |
CTD |
| G |
Dusp2 |
dual specificity phosphatase 2 |
|
multiple interactions |
EXP |
2 |
127,161,895 |
127,164,113 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
affects expression |
ISO |
10 |
98,725,865 |
98,730,123 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
ISO |
10 |
98,725,865 |
98,730,123 |
RGD:6480464 |
CTD |
| G |
Dvl1 |
dishevelled, dsh homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
4 |
155,221,521 |
155,233,412 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
increases expression |
ISO |
5 |
115,747,119 |
115,750,999 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
multiple interactions |
ISO |
6 |
83,958,584 |
84,161,036 |
RGD:6480464 |
CTD |
| G |
E2f6 |
E2F transcription factor 6 |
|
decreases expression |
ISO |
12 |
16,817,771 |
16,833,558 |
RGD:6480464 |
CTD |
| G |
Ebi3 |
Epstein-Barr virus induced gene 3 |
|
increases expression |
ISO |
17 |
56,092,046 |
56,096,445 |
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
increases expression |
ISO |
2 |
180,882,397 |
180,891,720 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
|
affects methylation |
ISO |
11 |
28,753,205 |
28,826,743 |
RGD:6480464 |
CTD |
| G |
EG628324 |
predicted gene, EG628324 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
EG628324 |
predicted gene, EG628324 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
EG628324 |
predicted gene, EG628324 |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like domain 7 |
|
multiple interactions |
ISO |
2 |
26,436,576 |
26,448,202 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like domain 7 |
|
increases expression |
ISO |
2 |
26,436,576 |
26,448,202 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Ehd3 |
EH-domain containing 3 |
|
multiple interactions |
ISO |
17 |
74,154,181 |
74,181,433 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
affects response to substance |
ISO |
17 |
35,035,444 |
35,050,992 |
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
affects methylation |
ISO |
17 |
79,251,890 |
79,281,912 |
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4, gamma 1 |
|
increases expression |
ISO |
16 |
20,672,822 |
20,692,956 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
|
multiple interactions |
ISO |
8 |
4,284,782 |
4,325,100 |
RGD:6480464 |
CTD |
| G |
Elavl3 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) |
|
increases expression |
ISO |
9 |
21,819,449 |
21,856,467 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
multiple interactions |
ISO |
13 |
98,011,060 |
98,022,995 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, alpha non-neuron |
|
increases expression |
ISO |
4 |
149,611,306 |
149,622,982 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma neuronal |
|
multiple interactions |
ISO |
6 |
124,710,073 |
124,719,527 |
RGD:6480464 |
CTD |
| G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
|
multiple interactions |
ISO |
14 |
77,556,623 |
78,121,214 |
RGD:6480464 |
CTD |
| G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
|
decreases expression |
ISO |
14 |
77,556,623 |
78,121,214 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
affects methylation |
ISO |
15 |
81,416,644 |
81,482,507 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
15 |
81,416,644 |
81,482,507 |
RGD:6480464 |
CTD |
| G |
Epb4.1 |
erythrocyte protein band 4.1 |
|
affects expression |
ISO |
4 |
131,479,328 |
131,631,228 |
RGD:6480464 |
CTD |
| G |
Epb4.1l3 |
erythrocyte protein band 4.1-like 3 |
|
affects expression |
ISO |
17 |
69,506,150 |
69,639,329 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
affects expression |
ISO |
17 |
88,035,319 |
88,050,467 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
multiple interactions |
ISO |
17 |
88,035,319 |
88,050,467 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
decreases methylation |
ISO |
6 |
42,308,486 |
42,323,267 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
increases expression |
ISO |
6 |
42,308,486 |
42,323,267 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects methylation |
ISO |
4 |
140,857,155 |
140,885,293 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
increases expression |
ISO |
1 |
182,919,687 |
182,947,626 |
RGD:6480464 |
CTD |
| G |
Ephx3 |
epoxide hydrolase 3 |
|
increases expression |
ISO |
17 |
32,320,715 |
32,326,408 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
ISO |
5 |
137,924,248 |
137,927,044 |
RGD:6480464 |
CTD |
| G |
Eral1 |
Era (G-protein)-like 1 (E. coli) |
|
multiple interactions |
EXP |
11 |
77,886,878 |
77,893,885 |
RGD:6480464 |
CTD |
| G |
Eral1 |
Era (G-protein)-like 1 (E. coli) |
|
increases expression |
EXP |
11 |
77,886,878 |
77,893,885 |
RGD:6480464 |
CTD |
| G |
Erg |
avian erythroblastosis virus E-26 (v-ets) oncogene related |
|
decreases methylation |
ISO |
16 |
95,581,811 |
95,751,972 |
RGD:6480464 |
CTD |
| G |
Erg |
avian erythroblastosis virus E-26 (v-ets) oncogene related |
|
increases expression |
ISO |
16 |
95,581,811 |
95,751,972 |
RGD:6480464 |
CTD |
| G |
Erg |
avian erythroblastosis virus E-26 (v-ets) oncogene related |
|
increases expression |
ISO |
16 |
95,581,811 |
95,751,972 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
4 |
150,229,200 |
150,242,989 |
RGD:6480464 |
CTD |
| G |
Esam |
endothelial cell-specific adhesion molecule |
|
increases expression |
ISO |
9 |
37,335,674 |
37,345,904 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases stability |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
decreases methylation |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases expression |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
|
increases expression |
ISO |
9 |
32,503,627 |
32,565,405 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
affects expression |
ISO |
13 |
96,281,673 |
96,295,195 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
multiple interactions |
ISO |
3 |
10,012,606 |
10,016,610 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
increases expression |
ISO |
19 |
10,257,378 |
10,271,364 |
RGD:6480464 |
CTD |
| G |
Fam111a |
family with sequence similarity 111, member A |
|
increases expression |
ISO |
19 |
12,648,015 |
12,664,186 |
RGD:6480464 |
CTD |
| G |
Fam149b |
family with sequence similarity 149, member B |
|
increases expression |
ISO |
14 |
21,167,384 |
21,202,713 |
RGD:6480464 |
CTD |
| G |
Fam83a |
family with sequence similarity 83, member A |
|
multiple interactions |
ISO |
15 |
57,817,458 |
57,842,261 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
multiple interactions |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fate1 |
fetal and adult testis expressed 1 |
|
increases expression |
ISO |
X |
69,218,325 |
69,234,385 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose bisphosphatase 1 |
|
multiple interactions |
ISO |
13 |
62,966,113 |
62,989,596 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose bisphosphatase 2 |
|
multiple interactions |
ISO |
13 |
62,938,245 |
62,959,730 |
RGD:6480464 |
CTD |
| G |
Fbxo41 |
F-box protein 41 |
|
decreases expression |
ISO |
6 |
85,419,572 |
85,452,880 |
RGD:6480464 |
CTD |
| G |
Fcer1g |
Fc receptor, IgE, high affinity I, gamma polypeptide |
|
increases expression |
ISO |
1 |
173,159,703 |
173,164,480 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
8 |
26,629,244 |
26,686,186 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
affects methylation |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
multiple interactions |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
decreases methylation |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad gene |
|
increases expression |
ISO |
14 |
10,382,608 |
11,994,546 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
affects methylation |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
multiple interactions |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Filip1 |
filamin A interacting protein 1 |
|
increases expression |
ISO |
9 |
79,663,369 |
79,825,689 |
RGD:6480464 |
CTD |
| G |
Fkbp1b |
FK506 binding protein 1b |
|
affects expression |
ISO |
12 |
4,839,980 |
4,848,401 |
RGD:6480464 |
CTD |
| G |
Flt4 |
FMS-like tyrosine kinase 4 |
|
increases expression |
EXP |
11 |
49,423,181 |
49,466,241 |
RGD:6480464 |
CTD |
| G |
Flt4 |
FMS-like tyrosine kinase 4 |
|
multiple interactions |
EXP |
11 |
49,423,181 |
49,466,241 |
RGD:6480464 |
CTD |
| G |
Fmr1nb |
fragile X mental retardation 1 neighbor |
|
increases expression |
ISO |
X |
66,015,014 |
66,057,736 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
affects methylation |
ISO |
19 |
5,447,698 |
5,455,938 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
19 |
5,447,698 |
5,455,938 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
increases expression |
ISO |
5 |
32,438,845 |
32,460,213 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
multiple interactions |
ISO |
12 |
58,641,618 |
58,647,108 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
multiple interactions |
ISO |
13 |
31,898,515 |
31,902,504 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
multiple interactions |
ISO |
X |
7,156,819 |
7,172,360 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
decreases methylation |
EXP |
X |
7,156,819 |
7,172,360 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
multiple interactions |
EXP |
X |
7,156,819 |
7,172,360 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
increases expression |
EXP |
X |
7,156,819 |
7,172,360 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
increases expression |
EXP |
X |
7,156,819 |
7,172,360 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
decreases expression |
ISO |
17 |
18,013,435 |
18,020,903 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
multiple interactions |
ISO |
17 |
18,013,435 |
18,020,903 |
RGD:6480464 |
CTD |
| G |
Frat1 |
frequently rearranged in advanced T cell lymphomas |
|
increases expression |
EXP |
19 |
41,904,460 |
41,907,073 |
RGD:6480464 |
CTD |
| G |
Frat1 |
frequently rearranged in advanced T cell lymphomas |
|
multiple interactions |
EXP |
19 |
41,904,460 |
41,907,073 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
affects methylation |
ISO |
5 |
143,722,034 |
143,734,868 |
RGD:6480464 |
CTD |
| G |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
|
increases expression |
ISO |
17 |
56,125,934 |
56,136,304 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
increases expression |
ISO |
13 |
115,242,470 |
115,248,938 |
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
increases expression |
ISO |
16 |
37,777,141 |
37,836,602 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin heavy chain 1 |
|
increases expression |
ISO |
19 |
10,057,193 |
10,059,582 |
RGD:6480464 |
CTD |
| G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
|
multiple interactions |
ISO |
9 |
45,178,268 |
45,204,242 |
RGD:6480464 |
CTD |
| G |
Fyn |
Fyn proto-oncogene |
|
affects expression |
ISO |
10 |
39,089,605 |
39,285,187 |
RGD:6480464 |
CTD |
| G |
Fyn |
Fyn proto-oncogene |
|
increases expression |
ISO |
10 |
39,089,605 |
39,285,187 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
|
affects expression |
ISO |
6 |
129,483,210 |
129,492,349 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
|
increases expression |
ISO |
6 |
129,483,210 |
129,492,349 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
|
multiple interactions |
EXP |
6 |
129,483,210 |
129,492,349 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
|
decreases expression |
EXP |
6 |
129,483,210 |
129,492,349 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
|
increases expression |
ISO |
11 |
41,723,697 |
41,814,180 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
multiple interactions |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
decreases methylation |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gas2l1 |
growth arrest-specific 2 like 1 |
|
multiple interactions |
ISO |
11 |
4,954,134 |
4,965,330 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
ISO |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
7,536,386 |
7,544,941 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
multiple interactions |
ISO |
6 |
88,148,658 |
88,157,026 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
multiple interactions |
ISO |
2 |
9,778,705 |
9,800,227 |
RGD:6480464 |
CTD |
| G |
Gch1 |
GTP cyclohydrolase 1 |
|
increases expression |
ISO |
14 |
47,773,570 |
47,809,077 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
increases expression |
ISO |
14 |
34,736,773 |
34,748,471 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
affects expression |
ISO |
8 |
73,153,293 |
73,155,534 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
8 |
73,153,293 |
73,155,534 |
RGD:6480464 |
CTD |
| G |
Gfi1 |
growth factor independent 1 |
|
multiple interactions |
ISO |
5 |
108,145,674 |
108,153,363 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases expression |
ISO |
10 |
75,036,338 |
75,048,927 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects expression |
ISO |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
multiple interactions |
ISO |
X |
98,572,676 |
98,580,964 |
RGD:6480464 |
CTD |
| G |
Gjb3 |
gap junction protein, beta 3 |
|
decreases expression |
EXP |
4 |
127,002,479 |
127,008,080 |
RGD:6480464 |
CTD |
| G |
Gjc1 |
gap junction protein, gamma 1 |
|
decreases expression |
EXP |
11 |
102,660,792 |
102,681,000 |
RGD:6480464 |
CTD |
| G |
Gldc |
glycine decarboxylase |
|
increases expression |
ISO |
19 |
30,172,937 |
30,249,908 |
RGD:6480464 |
CTD |
| G |
Gli1 |
GLI-Kruppel family member GLI1 |
|
multiple interactions |
ISO |
10 |
126,766,938 |
126,778,635 |
RGD:6480464 |
CTD |
| G |
Gli2 |
GLI-Kruppel family member GLI2 |
|
decreases expression |
ISO |
1 |
120,730,638 |
120,950,196 |
RGD:6480464 |
CTD |
| G |
Gli2 |
GLI-Kruppel family member GLI2 |
|
multiple interactions |
ISO |
1 |
120,730,638 |
120,950,196 |
RGD:6480464 |
CTD |
| G |
Glipr1 |
GLI pathogenesis-related 1 (glioma) |
|
affects methylation |
ISO |
10 |
111,422,504 |
111,434,320 |
RGD:6480464 |
CTD |
| G |
Gm20117 |
predicted gene, 20117 |
|
multiple interactions |
EXP |
15 |
79,741,604 |
79,746,338 |
RGD:6480464 |
CTD |
| G |
Gmds |
GDP-mannose 4, 6-dehydratase |
|
decreases expression |
ISO |
13 |
31,911,455 |
32,430,413 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
multiple interactions |
EXP |
11 |
48,613,862 |
48,619,743 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
EXP |
11 |
48,613,862 |
48,619,743 |
RGD:6480464 |
CTD |
| G |
Got1l1 |
glutamic-oxaloacetic transaminase 1-like 1 |
|
increases expression |
ISO |
8 |
28,307,931 |
28,313,019 |
RGD:6480464 |
CTD |
| G |
Gpr162 |
G protein-coupled receptor 162 |
|
multiple interactions |
ISO |
6 |
124,808,462 |
124,813,935 |
RGD:6480464 |
CTD |
| G |
Gpr162 |
G protein-coupled receptor 162 |
|
decreases expression |
ISO |
6 |
124,808,462 |
124,813,935 |
RGD:6480464 |
CTD |
| G |
Gpr34 |
G protein-coupled receptor 34 |
|
affects expression |
ISO |
X |
13,209,895 |
13,217,984 |
RGD:6480464 |
CTD |
| G |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
|
affects expression |
ISO |
7 |
126,115,554 |
126,138,725 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gpx7 |
glutathione peroxidase 7 |
|
multiple interactions |
ISO |
4 |
108,072,822 |
108,079,318 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
increases expression |
ISO |
2 |
113,588,832 |
113,598,805 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
multiple interactions |
EXP |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
multiple interactions |
EXP |
6 |
42,195,934 |
42,200,440 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase, mu 2 |
|
multiple interactions |
ISO |
3 |
107,784,620 |
107,789,354 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase, mu 2 |
|
increases expression |
ISO |
3 |
107,784,620 |
107,789,354 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase, mu 3 |
|
multiple interactions |
ISO |
3 |
107,766,614 |
107,772,076 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
multiple interactions |
EXP |
19 |
47,929,479 |
47,939,280 |
RGD:6480464 |
CTD |
| G |
Gtf2h1 |
general transcription factor II H, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
54,051,464 |
54,079,170 |
RGD:6480464 |
CTD |
| G |
Gtpbp1 |
GTP binding protein 1 |
|
increases expression |
ISO |
15 |
79,521,326 |
79,551,909 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
multiple interactions |
ISO |
17 |
46,297,981 |
46,306,319 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
increases expression |
ISO |
17 |
46,297,981 |
46,306,319 |
RGD:6480464 |
CTD |
| G |
Gyk |
glycerol kinase |
|
decreases expression |
ISO |
X |
82,947,276 |
83,022,158 |
RGD:6480464 |
CTD |
| G |
Gypc |
glycophorin C |
|
decreases expression |
ISO |
18 |
32,687,974 |
32,719,688 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
increases expression |
EXP |
6 |
142,371,133 |
142,421,629 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
multiple interactions |
EXP |
6 |
142,371,133 |
142,421,629 |
RGD:6480464 |
CTD |
| G |
H19 |
H19 fetal liver mRNA |
|
multiple interactions |
ISO |
7 |
149,761,437 |
149,764,051 |
RGD:6480464 |
CTD |
| G |
H1f0 |
H1 histone family, member 0 |
|
multiple interactions |
ISO |
15 |
78,858,642 |
78,860,934 |
RGD:6480464 |
CTD |
| G |
H1foo |
H1 histone family, member O, oocyte-specific |
|
affects methylation |
EXP |
6 |
115,894,957 |
115,900,251 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
multiple interactions |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
multiple interactions |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
increases expression |
ISO |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases phosphorylation |
ISO |
9 |
44,142,798 |
44,144,160 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
affects localization |
ISO |
9 |
44,142,798 |
44,144,160 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
ISO |
9 |
44,142,798 |
44,144,160 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
9 |
44,142,798 |
44,144,160 |
RGD:6480464 |
CTD |
| G |
Has2 |
hyaluronan synthase 2 |
|
affects expression |
ISO |
15 |
56,497,182 |
56,526,101 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
multiple interactions |
ISO |
2 |
152,934,204 |
152,977,177 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
affects methylation |
ISO |
2 |
152,934,204 |
152,977,177 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
increases expression |
ISO |
2 |
152,934,204 |
152,977,177 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
decreases expression |
ISO |
10 |
36,694,350 |
36,721,694 |
RGD:6480464 |
CTD |
| G |
Hdgfrp2 |
hepatoma-derived growth factor, related protein 2 |
|
increases expression |
EXP |
17 |
56,219,080 |
56,240,019 |
RGD:6480464 |
CTD |
| G |
Hdgfrp2 |
hepatoma-derived growth factor, related protein 2 |
|
multiple interactions |
EXP |
17 |
56,219,080 |
56,240,019 |
RGD:6480464 |
CTD |
| G |
Hdhd2 |
haloacid dehalogenase-like hydrolase domain containing 2 |
|
multiple interactions |
ISO |
18 |
77,182,854 |
77,210,910 |
RGD:6480464 |
CTD |
| G |
Helb |
helicase (DNA) B |
|
increases expression |
ISO |
10 |
119,520,664 |
119,550,021 |
RGD:6480464 |
CTD |
| G |
Hhip |
Hedgehog-interacting protein |
|
multiple interactions |
ISO |
8 |
82,489,750 |
82,581,907 |
RGD:6480464 |
CTD |
| G |
Hic1 |
hypermethylated in cancer 1 |
|
increases expression |
ISO |
11 |
74,978,067 |
74,983,757 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
multiple interactions |
ISO |
12 |
75,008,854 |
75,048,517 |
RGD:6480464 |
CTD |
| G |
Hist1h1c |
histone cluster 1, H1c |
|
multiple interactions |
ISO |
13 |
23,830,676 |
23,832,236 |
RGD:6480464 |
CTD |
| G |
Hist2h2aa1 |
histone cluster 2, H2aa1 |
|
increases expression |
ISO |
3 |
96,043,639 |
96,044,216 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
multiple interactions |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
multiple interactions |
EXP |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
increases expression |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
increases acetylation |
EXP |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hltf |
helicase-like transcription factor |
|
affects methylation |
ISO |
3 |
19,957,811 |
20,018,376 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
decreases expression |
ISO |
5 |
149,858,803 |
149,864,613 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
5 |
149,858,803 |
149,864,613 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmha1 |
histocompatibility (minor) HA-1 |
|
increases expression |
ISO |
10 |
79,479,417 |
79,494,216 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression |
ISO |
6 |
51,410,433 |
51,419,893 |
RGD:6480464 |
CTD |
| G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
|
increases expression |
ISO |
6 |
117,850,358 |
117,875,640 |
RGD:6480464 |
CTD |
| G |
Hoxa5 |
homeobox A5 |
|
multiple interactions |
ISO |
6 |
52,151,753 |
52,154,586 |
RGD:6480464 |
CTD |
| G |
Hoxa9 |
homeobox A9 |
|
increases expression |
ISO |
6 |
52,174,053 |
52,177,369 |
RGD:6480464 |
CTD |
| G |
Hoxb13 |
homeobox B13 |
|
affects expression |
ISO |
11 |
96,055,675 |
96,057,913 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeobox B4 |
|
multiple interactions |
ISO |
11 |
96,179,581 |
96,182,952 |
RGD:6480464 |
CTD |
| G |
Hoxd3 |
homeobox D3 |
|
decreases methylation |
ISO |
2 |
74,550,050 |
74,586,328 |
RGD:6480464 |
CTD |
| G |
Hoxd3 |
homeobox D3 |
|
increases expression |
ISO |
2 |
74,550,050 |
74,586,328 |
RGD:6480464 |
CTD |
| G |
Hpcal1 |
hippocalcin-like 1 |
|
multiple interactions |
ISO |
12 |
17,697,620 |
17,798,732 |
RGD:6480464 |
CTD |
| G |
Hps1 |
Hermansky-Pudlak syndrome 1 homolog (human) |
|
affects expression |
ISO |
19 |
42,829,686 |
42,854,466 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
affects expression |
ISO |
5 |
101,108,505 |
101,148,702 |
RGD:6480464 |
CTD |
| G |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
multiple interactions |
EXP |
5 |
40,005,174 |
40,035,870 |
RGD:6480464 |
CTD |
| G |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
increases expression |
EXP |
5 |
40,005,174 |
40,035,870 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
ISO |
8 |
108,042,646 |
108,047,888 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
ISO |
8 |
108,042,646 |
108,047,888 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
decreases expression |
ISO |
4 |
59,594,435 |
59,631,566 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
increases expression |
ISO |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
affects methylation |
ISO |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
ISO |
18 |
35,097,068 |
35,114,005 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases response to substance |
ISO |
18 |
35,097,068 |
35,114,005 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
ISO |
18 |
35,097,068 |
35,114,005 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hvcn1 |
hydrogen voltage-gated channel 1 |
|
increases expression |
ISO |
5 |
122,659,746 |
122,692,306 |
RGD:6480464 |
CTD |
| G |
Ibtk |
inhibitor of Bruton agammaglobulinemia tyrosine kinase |
|
decreases methylation |
EXP |
9 |
85,580,963 |
85,637,766 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
affects methylation |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Icam2 |
intercellular adhesion molecule 2 |
|
increases expression |
ISO |
11 |
106,238,970 |
106,243,955 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
ISO |
12 |
25,778,664 |
25,780,957 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
12 |
25,778,664 |
25,780,957 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
4 |
135,699,737 |
135,701,307 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
increases expression |
ISO |
13 |
48,356,796 |
48,359,405 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ifi27l1 |
interferon, alpha-inducible protein 27 like 1 |
|
increases expression |
ISO |
12 |
104,672,399 |
104,678,455 |
RGD:6480464 |
CTD |
| G |
Ifi30 |
interferon gamma inducible protein 30 |
|
multiple interactions |
ISO |
8 |
73,286,672 |
73,290,562 |
RGD:6480464 |
CTD |
| G |
Ifitm3 |
interferon induced transmembrane protein 3 |
|
increases expression |
ISO |
7 |
148,195,489 |
148,196,643 |
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
multiple interactions |
ISO |
4 |
88,167,929 |
88,168,698 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases secretion |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ift74 |
intraflagellar transport 74 |
|
affects expression |
ISO |
4 |
94,281,211 |
94,359,924 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
7 |
149,836,673 |
149,846,940 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
ISO |
1 |
72,904,639 |
72,921,439 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
15 |
101,974,617 |
101,979,943 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
affects methylation |
ISO |
5 |
77,778,265 |
77,837,070 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
increases expression |
ISO |
5 |
77,778,265 |
77,837,070 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
increases expression |
ISO |
5 |
77,778,265 |
77,837,070 |
RGD:6480464 |
CTD |
| G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
multiple interactions |
ISO |
11 |
98,326,007 |
98,407,345 |
RGD:6480464 |
CTD |
| G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
affects methylation |
ISO |
11 |
98,326,007 |
98,407,345 |
RGD:6480464 |
CTD |
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
increases expression |
ISO |
6 |
67,242,012 |
67,326,131 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
1 |
20,720,986 |
20,724,577 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
increases expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
affects expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
affects expression |
ISO |
7 |
132,695,796 |
132,722,988 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6ra |
interleukin 6 receptor, alpha |
|
increases expression |
ISO |
3 |
89,673,246 |
89,717,084 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
increases expression |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
multiple interactions |
ISO |
15 |
9,435,914 |
9,459,631 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
affects methylation |
ISO |
15 |
9,435,914 |
9,459,631 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
decreases expression |
EXP |
15 |
9,435,914 |
9,459,631 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Ing1 |
inhibitor of growth family, member 1 |
|
affects methylation |
ISO |
8 |
11,556,066 |
11,563,250 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
ISO |
5 |
28,397,952 |
28,405,202 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
increases expression |
ISO |
1 |
123,200,930 |
123,229,157 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
11 |
53,583,516 |
53,591,876 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
increases expression |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
increases expression |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
multiple interactions |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Irf8 |
interferon regulatory factor 8 |
|
multiple interactions |
ISO |
8 |
123,260,276 |
123,280,594 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
increases expression |
ISO |
8 |
10,986,961 |
11,008,430 |
RGD:6480464 |
CTD |
| G |
Irx1 |
Iroquois related homeobox 1 (Drosophila) |
|
multiple interactions |
ISO |
13 |
72,095,680 |
72,101,171 |
RGD:6480464 |
CTD |
| G |
Irx4 |
Iroquois related homeobox 4 (Drosophila) |
|
affects expression |
ISO |
13 |
73,397,945 |
73,407,068 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin alpha 1 |
|
affects methylation |
ISO |
13 |
115,748,287 |
115,892,172 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
multiple interactions |
ISO |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
affects expression |
ISO |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
multiple interactions |
ISO |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
decreases expression |
ISO |
19 |
29,326,318 |
29,387,570 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
decreases methylation |
ISO |
19 |
29,326,318 |
29,387,570 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Junb |
Jun-B oncogene |
|
affects methylation |
ISO |
8 |
87,500,811 |
87,502,617 |
RGD:6480464 |
CTD |
| G |
Junb |
Jun-B oncogene |
|
affects expression |
ISO |
8 |
87,500,811 |
87,502,617 |
RGD:6480464 |
CTD |
| G |
Jund |
Jun proto-oncogene related gene d |
|
multiple interactions |
ISO |
8 |
73,221,638 |
73,224,515 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
increases expression |
ISO |
11 |
100,231,933 |
100,259,053 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
multiple interactions |
ISO |
11 |
100,231,933 |
100,259,053 |
RGD:6480464 |
CTD |
| G |
Kcnip4 |
Kv channel interacting protein 4 |
|
increases expression |
ISO |
5 |
48,780,742 |
49,280,796 |
RGD:6480464 |
CTD |
| G |
Kcnj13 |
potassium inwardly-rectifying channel, subfamily J, member 13 |
|
affects expression |
ISO |
1 |
89,282,859 |
89,291,304 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases expression |
ISO |
6 |
142,513,459 |
142,519,876 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
increases expression |
ISO |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kdelr1 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
|
affects methylation |
ISO |
7 |
53,128,210 |
53,139,096 |
RGD:6480464 |
CTD |
| G |
Kdm5c |
lysine (K)-specific demethylase 5C |
|
increases expression |
ISO |
X |
148,667,773 |
148,708,897 |
RGD:6480464 |
CTD |
| G |
Keap1 |
kelch-like ECH-associated protein 1 |
|
multiple interactions |
ISO |
9 |
21,034,174 |
21,043,776 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
increases expression |
ISO |
1 |
135,223,789 |
135,226,299 |
RGD:6480464 |
CTD |
| G |
Kiss1r |
KISS1 receptor |
|
increases expression |
ISO |
10 |
79,379,716 |
79,385,018 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
multiple interactions |
EXP |
15 |
38,224,168 |
38,230,462 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
multiple interactions |
ISO |
14 |
99,697,910 |
99,712,631 |
RGD:6480464 |
CTD |
| G |
Krcc1 |
lysine-rich coiled-coil 1 |
|
increases expression |
ISO |
6 |
71,222,013 |
71,235,313 |
RGD:6480464 |
CTD |
| G |
Krt20 |
keratin 20 |
|
multiple interactions |
ISO |
11 |
99,289,717 |
99,299,467 |
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
increases expression |
ISO |
15 |
101,537,501 |
101,543,322 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
affects expression |
ISO |
15 |
101,827,142 |
101,834,773 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
15 |
101,827,142 |
101,834,773 |
RGD:6480464 |
CTD |
| G |
L1td1 |
LINE-1 type transposase domain containing 1 |
|
decreases methylation |
ISO |
4 |
98,393,445 |
98,405,177 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
multiple interactions |
ISO |
16 |
19,653,474 |
19,706,458 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
increases expression |
ISO |
16 |
19,653,474 |
19,706,458 |
RGD:6480464 |
CTD |
| G |
Lats1 |
large tumor suppressor |
|
affects methylation |
ISO |
10 |
7,401,007 |
7,436,259 |
RGD:6480464 |
CTD |
| G |
Lats1 |
large tumor suppressor |
|
multiple interactions |
ISO |
10 |
7,401,007 |
7,436,259 |
RGD:6480464 |
CTD |
| G |
Lats2 |
large tumor suppressor 2 |
|
affects methylation |
ISO |
14 |
58,308,499 |
58,364,960 |
RGD:6480464 |
CTD |
| G |
Lats2 |
large tumor suppressor 2 |
|
multiple interactions |
ISO |
14 |
58,308,499 |
58,364,960 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
increases expression |
ISO |
1 |
130,181,341 |
130,224,895 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
decreases expression |
ISO |
3 |
130,813,389 |
130,926,252 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases methylation |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Letm1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
|
multiple interactions |
ISO |
5 |
34,084,001 |
34,125,353 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactose binding, soluble 3 |
|
increases expression |
ISO |
14 |
47,993,535 |
48,005,842 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases expression |
ISO |
11 |
4,157,571 |
4,172,517 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
increases expression |
ISO |
10 |
57,786,295 |
57,887,437 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
decreases expression |
ISO |
18 |
56,867,467 |
56,913,078 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
multiple interactions |
ISO |
18 |
56,867,467 |
56,913,078 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
affects expression |
ISO |
18 |
52,676,892 |
52,689,362 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
ISO |
18 |
52,676,892 |
52,689,362 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
multiple interactions |
ISO |
14 |
70,009,283 |
70,095,641 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
increases expression |
ISO |
14 |
70,009,283 |
70,095,641 |
RGD:6480464 |
CTD |
| G |
Loxl4 |
lysyl oxidase-like 4 |
|
increases expression |
ISO |
19 |
42,666,769 |
42,687,296 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
multiple interactions |
ISO |
4 |
58,448,124 |
58,566,363 |
RGD:6480464 |
CTD |
| G |
Lpxn |
leupaxin |
|
increases expression |
ISO |
19 |
12,873,099 |
12,908,298 |
RGD:6480464 |
CTD |
| G |
Lrch4 |
leucine-rich repeats and calponin homology (CH) domain containing 4 |
|
increases expression |
ISO |
5 |
138,070,351 |
138,082,327 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
multiple interactions |
EXP |
9 |
110,854,049 |
110,886,570 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
increases expression |
EXP |
9 |
110,854,049 |
110,886,570 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
affects expression |
ISO |
9 |
110,854,049 |
110,886,570 |
RGD:6480464 |
CTD |
| G |
Lrrc23 |
leucine rich repeat containing 23 |
|
increases expression |
ISO |
6 |
124,719,881 |
124,729,736 |
RGD:6480464 |
CTD |
| G |
Lrrc3b |
leucine rich repeat containing 3B |
|
multiple interactions |
ISO |
14 |
16,190,029 |
16,271,501 |
RGD:6480464 |
CTD |
| G |
Lrrc3b |
leucine rich repeat containing 3B |
|
multiple interactions |
ISO |
14 |
16,190,029 |
16,271,501 |
RGD:6480464 |
CTD |
| G |
Lrrc3b |
leucine rich repeat containing 3B |
|
multiple interactions |
ISO |
14 |
16,190,029 |
16,271,501 |
RGD:6480464 |
CTD |
| G |
Lst1 |
leukocyte specific transcript 1 |
|
increases expression |
ISO |
17 |
35,322,040 |
35,325,385 |
RGD:6480464 |
CTD |
| G |
Lxn |
latexin |
|
affects expression |
ISO |
3 |
67,261,921 |
67,267,829 |
RGD:6480464 |
CTD |
| G |
Lztfl1 |
leucine zipper transcription factor-like 1 |
|
decreases expression |
ISO |
9 |
123,606,711 |
123,626,675 |
RGD:6480464 |
CTD |
| G |
Lztfl1 |
leucine zipper transcription factor-like 1 |
|
multiple interactions |
ISO |
9 |
123,606,711 |
123,626,675 |
RGD:6480464 |
CTD |
| G |
Mael |
maelstrom homolog (Drosophila) |
|
increases expression |
ISO |
1 |
168,131,516 |
168,168,875 |
RGD:6480464 |
CTD |
| G |
Maf |
avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog |
|
affects expression |
ISO |
8 |
118,227,153 |
118,230,794 |
RGD:6480464 |
CTD |
| G |
Magea10 |
melanoma antigen family A, 10 |
|
affects expression |
ISO |
X |
69,627,209 |
69,632,197 |
RGD:6480464 |
CTD |
| G |
Magea10 |
melanoma antigen family A, 10 |
|
increases expression |
ISO |
X |
69,627,209 |
69,632,197 |
RGD:6480464 |
CTD |
| G |
Magea9-ps |
melanoma antigen, family A, 9, pseudogene |
|
affects expression |
ISO |
X |
70,114,857 |
70,115,513 |
RGD:6480464 |
CTD |
| G |
Magea9-ps |
melanoma antigen, family A, 9, pseudogene |
|
increases expression |
ISO |
X |
70,114,857 |
70,115,513 |
RGD:6480464 |
CTD |
| G |
Mal |
myelin and lymphocyte protein, T cell differentiation protein |
|
increases expression |
ISO |
2 |
127,458,962 |
127,482,431 |
RGD:6480464 |
CTD |
| G |
Mal |
myelin and lymphocyte protein, T cell differentiation protein |
|
decreases methylation |
ISO |
2 |
127,458,962 |
127,482,431 |
RGD:6480464 |
CTD |
| G |
Man1b1 |
mannosidase, alpha, class 1B, member 1 |
|
increases expression |
ISO |
2 |
25,188,263 |
25,207,733 |
RGD:6480464 |
CTD |
| G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
multiple interactions |
ISO |
8 |
124,114,368 |
124,121,947 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
increases expression |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map3k3 |
mitogen-activated protein kinase kinase kinase 3 |
|
multiple interactions |
ISO |
11 |
105,946,216 |
106,016,760 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
decreases expression |
ISO |
18 |
4,331,325 |
4,352,951 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
|
affects methylation |
ISO |
1 |
132,950,281 |
132,994,120 |
RGD:6480464 |
CTD |
| G |
Mapre3 |
microtubule-associated protein, RP/EB family, member 3 |
|
multiple interactions |
ISO |
5 |
31,117,129 |
31,168,479 |
RGD:6480464 |
CTD |
| G |
Mark1 |
MAP/microtubule affinity-regulating kinase 1 |
|
increases expression |
ISO |
1 |
186,720,303 |
186,823,428 |
RGD:6480464 |
CTD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
decreases expression |
ISO |
16 |
23,451,858 |
23,520,663 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
increases expression |
ISO |
18 |
74,427,942 |
74,442,338 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
multiple interactions |
ISO |
18 |
70,727,946 |
70,785,785 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
multiple interactions |
ISO |
18 |
70,727,946 |
70,785,785 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
decreases activity |
ISO |
18 |
70,727,946 |
70,785,785 |
RGD:6480464 |
CTD |
| G |
Mbd3 |
methyl-CpG binding domain protein 3 |
|
increases expression |
ISO |
10 |
79,855,286 |
79,862,224 |
RGD:6480464 |
CTD |
| G |
Mbd3l2 |
methyl-CpG binding domain protein 3-like 2 |
|
increases expression |
ISO |
9 |
18,235,059 |
18,250,760 |
RGD:6480464 |
CTD |
| G |
Mbd5 |
methyl-CpG binding domain protein 5 |
|
multiple interactions |
ISO |
2 |
48,805,028 |
49,172,589 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance deficient 4 homolog (S. cerevisiae) |
|
affects methylation |
ISO |
16 |
15,623,990 |
15,637,493 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) |
|
affects methylation |
ISO |
8 |
77,633,427 |
77,652,338 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance deficient 7 (S. cerevisiae) |
|
affects methylation |
ISO |
5 |
138,605,817 |
138,613,090 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
affects expression |
ISO |
10 |
117,125,961 |
117,147,772 |
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
multiple interactions |
ISO |
X |
71,272,160 |
71,330,975 |
RGD:6480464 |
CTD |
| G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
|
increases expression |
ISO |
4 |
131,399,386 |
131,423,702 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
13 |
83,643,033 |
83,806,684 |
RGD:6480464 |
CTD |
| G |
Meg3 |
maternally expressed 3 |
|
multiple interactions |
ISO |
12 |
110,779,206 |
110,809,939 |
RGD:6480464 |
CTD |
| G |
Mfap2 |
microfibrillar-associated protein 2 |
|
affects expression |
ISO |
4 |
140,566,339 |
140,571,899 |
RGD:6480464 |
CTD |
| G |
Nipsnap1 |
4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1 (C. elegans) |
|
affects expression |
ISO |
11 |
4,774,006 |
4,794,203 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
multiple interactions |
ISO |
12 |
57,632,922 |
57,637,895 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
affects expression |
ISO |
12 |
57,632,922 |
57,637,895 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
increases expression |
ISO |
12 |
57,632,922 |
57,637,895 |
RGD:6480464 |
CTD |
| G |
Nkx2-9 |
NK2 transcription factor related, locus 9 (Drosophila) |
|
increases expression |
ISO |
12 |
57,712,380 |
57,714,271 |
RGD:6480464 |
CTD |
| G |
Nkx3-1 |
NK-3 transcription factor, locus 1 (Drosophila) |
|
increases expression |
ISO |
14 |
69,808,749 |
69,812,715 |
RGD:6480464 |
CTD |
| G |
Nmb |
neuromedin B |
|
increases expression |
ISO |
7 |
88,047,113 |
88,049,957 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
affects methylation |
ISO |
11 |
93,811,129 |
93,817,321 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
increases expression |
ISO |
2 |
157,385,846 |
157,388,258 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
multiple interactions |
ISO |
2 |
157,385,846 |
157,388,258 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
multiple interactions |
ISO |
2 |
26,313,422 |
26,359,342 |
RGD:6480464 |
CTD |
| G |
Npas4 |
neuronal PAS domain protein 4 |
|
increases expression |
ISO |
19 |
4,984,355 |
4,989,971 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin 1 |
|
decreases methylation |
ISO |
11 |
33,052,511 |
33,063,056 |
RGD:6480464 |
CTD |
| G |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
|
decreases methylation |
ISO |
14 |
71,047,109 |
71,052,891 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases methylation |
ISO |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
decreases expression |
ISO |
13 |
78,328,234 |
78,338,243 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
multiple interactions |
ISO |
13 |
78,328,234 |
78,338,243 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
decreases expression |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases expression |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
affects methylation |
ISO |
2 |
38,548,180 |
38,570,062 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuron-glia-CAM-related cell adhesion molecule |
|
affects expression |
ISO |
12 |
45,429,872 |
45,702,833 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
multiple interactions |
ISO |
8 |
130,882,973 |
131,029,376 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
decreases expression |
ISO |
17 |
56,890,748 |
56,896,953 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
multiple interactions |
ISO |
17 |
56,890,748 |
56,896,953 |
RGD:6480464 |
CTD |
| G |
Nt5e |
5' nucleotidase, ecto |
|
increases expression |
ISO |
9 |
88,222,447 |
88,266,927 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
increases expression |
ISO |
13 |
58,907,957 |
59,231,337 |
RGD:6480464 |
CTD |
| G |
Nubp2 |
nucleotide binding protein 2 |
|
increases expression |
ISO |
17 |
25,019,556 |
25,023,295 |
RGD:6480464 |
CTD |
| G |
Numa1 |
nuclear mitotic apparatus protein 1 |
|
multiple interactions |
ISO |
7 |
109,118,357 |
109,163,473 |
RGD:6480464 |
CTD |
| G |
Numa1 |
nuclear mitotic apparatus protein 1 |
|
decreases expression |
ISO |
7 |
109,118,357 |
109,163,473 |
RGD:6480464 |
CTD |
| G |
Nxf2 |
nuclear RNA export factor 2 |
|
increases expression |
ISO |
X |
131,479,070 |
131,499,293 |
RGD:6480464 |
CTD |
| G |
Nxph4 |
neurexophilin 4 |
|
decreases expression |
ISO |
10 |
126,962,529 |
126,971,615 |
RGD:6480464 |
CTD |
| G |
Nxph4 |
neurexophilin 4 |
|
multiple interactions |
ISO |
10 |
126,962,529 |
126,971,615 |
RGD:6480464 |
CTD |
| G |
Nxt2 |
nuclear transport factor 2-like export factor 2 |
|
increases expression |
ISO |
X |
138,662,480 |
138,674,235 |
RGD:6480464 |
CTD |
| G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
|
increases expression |
ISO |
5 |
121,180,342 |
121,199,857 |
RGD:6480464 |
CTD |
| G |
Ola1 |
Obg-like ATPase 1 |
|
multiple interactions |
ISO |
2 |
72,930,858 |
73,052,504 |
RGD:6480464 |
CTD |
| G |
Ola1 |
Obg-like ATPase 1 |
|
decreases expression |
ISO |
2 |
72,930,858 |
73,052,504 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
affects methylation |
EXP |
10 |
3,308,332 |
3,557,940 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
10 |
3,308,332 |
3,557,940 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
increases expression |
EXP |
15 |
6,763,577 |
6,824,313 |
RGD:6480464 |
CTD |
| G |
Prox1 |
prospero-related homeobox 1 |
|
increases expression |
ISO |
1 |
191,945,654 |
191,994,559 |
RGD:6480464 |
CTD |
| G |
Psip1 |
PC4 and SFRS1 interacting protein 1 |
|
multiple interactions |
ISO |
4 |
83,101,584 |
83,132,294 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
multiple interactions |
ISO |
3 |
94,688,246 |
94,690,880 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
decreases expression |
ISO |
3 |
94,688,246 |
94,690,880 |
RGD:6480464 |
CTD |
| G |
Pstpip1 |
proline-serine-threonine phosphatase-interacting protein 1 |
|
increases expression |
ISO |
9 |
55,937,783 |
55,976,697 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched homolog 1 |
|
multiple interactions |
ISO |
13 |
63,612,841 |
63,666,828 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched homolog 1 |
|
multiple interactions |
EXP |
13 |
63,612,841 |
63,666,828 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched homolog 1 |
|
decreases methylation |
EXP |
13 |
63,612,841 |
63,666,828 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases methylation |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
EXP |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
increases expression |
EXP |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
affects expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
decreases methylation |
ISO |
6 |
124,670,736 |
124,688,727 |
RGD:6480464 |
CTD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
increases expression |
ISO |
6 |
124,670,736 |
124,688,727 |
RGD:6480464 |
CTD |
| G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
|
decreases expression |
ISO |
9 |
56,842,775 |
56,910,615 |
RGD:6480464 |
CTD |
| G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
|
multiple interactions |
ISO |
9 |
56,842,775 |
56,910,615 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
affects methylation |
ISO |
14 |
12,386,067 |
13,074,553 |
RGD:6480464 |
CTD |
| G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
affects methylation |
ISO |
10 |
27,794,626 |
28,317,203 |
RGD:6480464 |
CTD |
| G |
Pxdc1 |
PX domain containing 1 |
|
increases expression |
ISO |
13 |
34,719,710 |
34,744,550 |
RGD:6480464 |
CTD |
| G |
Pxdn |
peroxidasin homolog (Drosophila) |
|
multiple interactions |
ISO |
12 |
30,622,901 |
30,702,523 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
increases expression |
ISO |
7 |
135,134,887 |
135,137,381 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
7 |
135,134,887 |
135,137,381 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
affects methylation |
ISO |
7 |
135,134,887 |
135,137,381 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
7 |
135,134,887 |
135,137,381 |
RGD:6480464 |
CTD |
| G |
Qpct |
glutaminyl-peptide cyclotransferase (glutaminyl cyclase) |
|
increases expression |
ISO |
17 |
79,451,246 |
79,489,583 |
RGD:6480464 |
CTD |
| G |
Qpct |
glutaminyl-peptide cyclotransferase (glutaminyl cyclase) |
|
affects expression |
ISO |
17 |
79,451,246 |
79,489,583 |
RGD:6480464 |
CTD |
| G |
Rab13 |
RAB13, member RAS oncogene family |
|
increases expression |
ISO |
3 |
90,024,739 |
90,029,885 |
RGD:6480464 |
CTD |
| G |
Rab13 |
RAB13, member RAS oncogene family |
|
decreases methylation |
ISO |
3 |
90,024,739 |
90,029,885 |
RGD:6480464 |
CTD |
| G |
Rab5c |
RAB5C, member RAS oncogene family |
|
increases expression |
ISO |
11 |
100,576,580 |
100,599,444 |
RGD:6480464 |
CTD |
| G |
Rac2 |
RAS-related C3 botulinum substrate 2 |
|
affects expression |
ISO |
15 |
78,389,599 |
78,403,213 |
RGD:6480464 |
CTD |
| G |
Rad17 |
RAD17 homolog (S. pombe) |
|
decreases expression |
ISO |
13 |
101,387,119 |
101,421,014 |
RGD:6480464 |
CTD |
| G |
Rad23b |
RAD23b homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
4 |
55,362,914 |
55,405,109 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog |
|
affects localization |
ISO |
2 |
118,938,553 |
118,961,806 |
RGD:6480464 |
CTD |
| G |
Rag1 |
recombination activating gene 1 |
|
increases expression |
ISO |
2 |
101,478,409 |
101,489,689 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
affects expression |
ISO |
2 |
28,368,687 |
28,408,602 |
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (calcitonin) activity modifying protein 2 |
|
affects methylation |
ISO |
11 |
101,107,648 |
101,109,564 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor alpha |
|
increases expression |
ISO |
9 |
68,501,609 |
69,226,838 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
affects methylation |
ISO |
3 |
90,404,137 |
90,406,624 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
multiple interactions |
ISO |
3 |
90,404,137 |
90,406,624 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
increases expression |
ISO |
3 |
90,404,137 |
90,406,624 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium binding protein A4 |
|
affects methylation |
ISO |
3 |
90,407,692 |
90,409,967 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium binding protein A4 |
|
increases expression |
ISO |
3 |
90,407,692 |
90,409,967 |
RGD:6480464 |
CTD |
| G |
S100a5 |
S100 calcium binding protein A5 |
|
increases expression |
ISO |
3 |
90,412,444 |
90,415,702 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 (calcyclin) |
|
affects methylation |
ISO |
3 |
90,416,816 |
90,418,336 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 (calcyclin) |
|
increases expression |
ISO |
3 |
90,416,816 |
90,418,336 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
|
affects expression |
ISO |
3 |
90,472,993 |
90,473,956 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
affects expression |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
increases expression |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
multiple interactions |
ISO |
3 |
115,413,351 |
115,417,973 |
RGD:6480464 |
CTD |
| G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
|
multiple interactions |
ISO |
9 |
20,770,396 |
20,781,237 |
RGD:6480464 |
CTD |
| G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
|
multiple interactions |
ISO |
13 |
51,503,987 |
51,518,166 |
RGD:6480464 |
CTD |
| G |
Samd5 |
sterile alpha motif domain containing 5 |
|
decreases expression |
ISO |
10 |
9,347,057 |
9,395,006 |
RGD:6480464 |
CTD |
| G |
Samd5 |
sterile alpha motif domain containing 5 |
|
multiple interactions |
ISO |
10 |
9,347,057 |
9,395,006 |
RGD:6480464 |
CTD |
| G |
Sash3 |
SAM and SH3 domain containing 3 |
|
increases expression |
ISO |
X |
45,499,704 |
45,514,740 |
RGD:6480464 |
CTD |
| G |
Satb1 |
special AT-rich sequence binding protein 1 |
|
affects expression |
ISO |
17 |
51,875,512 |
51,972,615 |
RGD:6480464 |
CTD |
| G |
Scand1 |
SCAN domain-containing 1 |
|
increases expression |
ISO |
2 |
156,137,582 |
156,138,440 |
RGD:6480464 |
CTD |
| G |
Scara3 |
scavenger receptor class A, member 3 |
|
decreases methylation |
ISO |
14 |
66,538,232 |
66,572,581 |
RGD:6480464 |
CTD |
| G |
Scg5 |
secretogranin V |
|
increases expression |
ISO |
2 |
113,616,470 |
113,669,248 |
RGD:6480464 |
CTD |
| G |
Scgb3a1 |
secretoglobin, family 3A, member 1 |
|
decreases methylation |
ISO |
11 |
49,477,112 |
49,478,620 |
RGD:6480464 |
CTD |
| G |
Scgb3a1 |
secretoglobin, family 3A, member 1 |
|
increases expression |
ISO |
11 |
49,477,112 |
49,478,620 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
multiple interactions |
EXP |
11 |
88,785,334 |
88,816,756 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
decreases expression |
EXP |
11 |
88,785,334 |
88,816,756 |
RGD:6480464 |
CTD |
| G |
Scrn1 |
secernin 1 |
|
increases expression |
ISO |
6 |
54,458,810 |
54,516,376 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
affects expression |
ISO |
15 |
32,850,478 |
32,964,476 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
increases expression |
ISO |
2 |
164,249,747 |
164,268,688 |
RGD:6480464 |
CTD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
multiple interactions |
EXP |
12 |
93,044,483 |
93,087,597 |
RGD:6480464 |
CTD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
decreases expression |
EXP |
12 |
93,044,483 |
93,087,597 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin, lymphocyte |
|
increases expression |
ISO |
1 |
165,992,207 |
166,010,916 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
affects expression |
ISO |
15 |
3,220,767 |
3,230,508 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
|
increases expression |
ISO |
1 |
109,408,000 |
109,422,177 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serine (or cysteine) peptidase inhibitor, clade B, member 5 |
|
affects expression |
ISO |
1 |
108,757,757 |
108,779,925 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serine (or cysteine) peptidase inhibitor, clade B, member 5 |
|
multiple interactions |
ISO |
1 |
108,757,757 |
108,779,925 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serine (or cysteine) peptidase inhibitor, clade B, member 5 |
|
increases expression |
ISO |
1 |
108,757,757 |
108,779,925 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
increases expression |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Sfpi1 |
SFFV proviral integration 1 |
|
affects methylation |
ISO |
2 |
90,936,954 |
90,955,913 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
increases expression |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
increases expression |
EXP |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
EXP |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp110 |
Sp110 nuclear body protein |
|
increases expression |
ISO |
1 |
87,473,474 |
87,500,466 |
RGD:6480464 |
CTD |
| G |
Sp3 |
trans-acting transcription factor 3 |
|
multiple interactions |
ISO |
2 |
72,774,487 |
72,818,503 |
RGD:6480464 |
CTD |
| G |
Sp3 |
trans-acting transcription factor 3 |
|
multiple interactions |
ISO |
2 |
72,774,487 |
72,818,503 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
multiple interactions |
ISO |
11 |
55,208,003 |
55,233,582 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
multiple interactions |
ISO |
11 |
55,208,003 |
55,233,582 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
increases expression |
ISO |
11 |
55,208,003 |
55,233,582 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
increases expression |
ISO |
11 |
55,208,003 |
55,233,582 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
increases expression |
ISO |
11 |
116,393,225 |
116,397,989 |
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
increases expression |
EXP |
3 |
92,287,876 |
92,289,803 |
RGD:6480464 |
CTD |
| G |
Sprr2a1 |
small proline-rich protein 2A1 |
|
multiple interactions |
EXP |
3 |
92,019,757 |
92,026,413 |
RGD:6480464 |
CTD |
| G |
Sprr2a1 |
small proline-rich protein 2A1 |
|
increases expression |
EXP |
3 |
92,019,757 |
92,026,413 |
RGD:6480464 |
CTD |
| G |
Sprr2a1 |
small proline-rich protein 2A1 |
|
increases expression |
ISO |
3 |
92,019,757 |
92,026,413 |
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin alpha, non-erythrocytic 1 |
|
multiple interactions |
ISO |
2 |
29,821,080 |
29,886,971 |
RGD:6480464 |
CTD |
| G |
Spz1 |
spermatogenic leucine zipper 1 |
|
increases expression |
ISO |
13 |
93,344,586 |
93,346,187 |
RGD:6480464 |
CTD |
| G |
Sqrdl |
sulfide quinone reductase-like (yeast) |
|
increases expression |
ISO |
2 |
122,591,095 |
122,635,289 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
increases expression |
ISO |
10 |
61,957,176 |
61,970,503 |
RGD:6480464 |
CTD |
| G |
Ssbp2 |
single-stranded DNA binding protein 2 |
|
multiple interactions |
ISO |
13 |
91,600,702 |
91,845,780 |
RGD:6480464 |
CTD |
| G |
Ssbp2 |
single-stranded DNA binding protein 2 |
|
increases expression |
ISO |
13 |
91,600,702 |
91,845,780 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
affects methylation |
ISO |
16 |
23,889,667 |
23,890,930 |
RGD:6480464 |
CTD |
| G |
Sstr5 |
somatostatin receptor 5 |
|
multiple interactions |
ISO |
17 |
25,626,820 |
25,634,198 |
RGD:6480464 |
CTD |
| G |
Ssxb2 |
synovial sarcoma, X member B, breakpoint 2 |
|
affects expression |
ISO |
X |
8,031,469 |
8,038,852 |
RGD:6480464 |
CTD |
| G |
Ssxb2 |
synovial sarcoma, X member B, breakpoint 2 |
|
increases expression |
ISO |
X |
8,031,469 |
8,038,852 |
RGD:6480464 |
CTD |
| G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
|
multiple interactions |
EXP |
7 |
90,780,527 |
90,790,838 |
RGD:6480464 |
CTD |
| G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
|
decreases expression |
EXP |
7 |
90,780,527 |
90,790,838 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
multiple interactions |
ISO |
11 |
31,259,441 |
31,270,061 |
RGD:6480464 |
CTD |
| G |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
|
multiple interactions |
ISO |
1 |
53,812,356 |
53,842,059 |
RGD:6480464 |
CTD |
| G |
Svs2 |
seminal vesicle secretory protein 2 |
|
affects expression |
ISO |
2 |
164,061,665 |
164,064,077 |
RGD:6480464 |
CTD |
| G |
Swap70 |
SWA-70 protein |
|
increases expression |
ISO |
7 |
117,365,217 |
117,427,020 |
RGD:6480464 |
CTD |
| G |
Tpm2 |
tropomyosin 2, beta |
|
affects expression |
ISO |
4 |
43,527,584 |
43,536,260 |
RGD:6480464 |
CTD |
| G |
Tpm3 |
tropomyosin 3, gamma |
|
decreases expression |
ISO |
3 |
89,876,616 |
89,904,526 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
decreases expression |
ISO |
8 |
74,659,191 |
74,677,028 |
RGD:6480464 |
CTD |
| G |
Tpt1 |
tumor protein, translationally-controlled 1 |
|
decreases expression |
ISO |
14 |
76,245,063 |
76,248,110 |
RGD:6480464 |
CTD |
| G |
Tpt1 |
tumor protein, translationally-controlled 1 |
|
multiple interactions |
ISO |
14 |
76,245,063 |
76,248,110 |
RGD:6480464 |
CTD |
| G |
Trim10 |
tripartite motif-containing 10 |
|
decreases expression |
ISO |
17 |
37,006,519 |
37,014,778 |
RGD:6480464 |
CTD |
| G |
Trim23 |
tripartite motif-containing 23 |
|
increases expression |
ISO |
13 |
104,969,178 |
104,992,128 |
RGD:6480464 |
CTD |
| G |
Trim8 |
tripartite motif-containing 8 |
|
increases expression |
ISO |
19 |
46,576,138 |
46,590,945 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases acetylation |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
decreases ubiquitination |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases phosphorylation |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53inp1 |
transformation related protein 53 inducible nuclear protein 1 |
|
multiple interactions |
ISO |
4 |
11,083,588 |
11,101,524 |
RGD:6480464 |
CTD |
| G |
Trp73 |
transformation related protein 73 |
|
decreases methylation |
ISO |
4 |
153,430,358 |
153,514,317 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
decreases expression |
ISO |
10 |
77,370,467 |
77,432,617 |
RGD:6480464 |
CTD |
| G |
Ttbk2 |
tau tubulin kinase 2 |
|
affects expression |
ISO |
2 |
120,558,552 |
120,676,320 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIA |
|
multiple interactions |
ISO |
13 |
34,166,147 |
34,169,877 |
RGD:6480464 |
CTD |
| G |
Tubb2b |
tubulin, beta 2B class IIB |
|
increases expression |
ISO |
13 |
34,218,877 |
34,222,223 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
affects expression |
ISO |
8 |
125,935,464 |
125,945,910 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
multiple interactions |
ISO |
8 |
125,935,464 |
125,945,910 |
RGD:6480464 |
CTD |
| G |
Tyrobp |
TYRO protein tyrosine kinase binding protein |
|
multiple interactions |
EXP |
7 |
31,198,807 |
31,202,601 |
RGD:6480464 |
CTD |
| G |
Tyrobp |
TYRO protein tyrosine kinase binding protein |
|
decreases expression |
EXP |
7 |
31,198,807 |
31,202,601 |
RGD:6480464 |
CTD |
| G |
Ubac1 |
ubiquitin associated domain containing 1 |
|
increases expression |
ISO |
2 |
25,852,478 |
25,877,280 |
RGD:6480464 |
CTD |
| G |
Ubxn6 |
UBX domain protein 6 |
|
increases expression |
ISO |
17 |
56,207,676 |
56,214,412 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
|
multiple interactions |
ISO |
5 |
67,067,360 |
67,078,473 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
|
increases expression |
ISO |
5 |
67,067,360 |
67,078,473 |
RGD:6480464 |
CTD |
| G |
Vamp8 |
vesicle-associated membrane protein 8 |
|
affects expression |
ISO |
6 |
72,335,215 |
72,340,661 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
multiple interactions |
ISO |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects methylation |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vimp |
VCP-interacting membrane protein |
|
multiple interactions |
EXP |
7 |
73,224,535 |
73,234,291 |
RGD:6480464 |
CTD |
| G |
Vimp |
VCP-interacting membrane protein |
|
decreases expression |
EXP |
7 |
73,224,535 |
73,234,291 |
RGD:6480464 |
CTD |
Term paths to the root
|